Grupo ALPHA PRO SERVIÇOS

The global moisturizing cream market is a central segment of the skincare and cosmetics industry. Moisturizing creams are designed to maintain the skin’s hydration, protect against dryness, and improve skin texture, serving both aesthetic and dermatological purposes. They are widely used by consumers across all age groups, making them one of the most consistent and high-demand products in the personal care sector.

The growing awareness of skincare routines, rising disposable incomes, and increasing prevalence of skin-related issues due to pollution and lifestyle changes have fueled market growth. Furthermore, the popularity of natural, organic, and multifunctional skincare products has expanded consumer choices and created new opportunities for manufacturers.

The moisturizing cream market is expected to witness market growth at a rate of 5%   in the forecast period of 2021 to 2028 and is expected to reach the value of USD 17,607.57 million by 2028. 

Equip yourself with actionable insights and trends from…

Foley Catheters Market Economic Outlook

The Foley Catheters Market has a positive economic outlook, driven by several macro and microeconomic factors. The market's growth is inherently tied to the increasing global healthcare expenditure, which is being driven by a growing and aging population. As more people enter old age, the prevalence of urological disorders and the need for surgical procedures increases, leading to a steady and reliable demand for Foley catheters. The economic value of the market is not just in the sale of the devices themselves, but also in the cost savings associated with improved patient outcomes.

The shift towards advanced, infection-resistant catheters, while potentially higher in initial cost, provides long-term economic benefits by reducing the incidence of costly hospital-acquired infections and reducing overall healthcare spending. The economic outlook is also buoyed by the expanding healthcare infrastructure in developing economies. As these countries invest in building new hospitals and…

Cell Viability Assays Market Economic Outlook

The Cell Viability Assays Market has a very positive economic outlook, driven by the increasing value proposition of cell-based assays in various sectors. The economic value of these technologies is not only in the sales of instruments and reagents but also in the long-term cost savings they provide by enabling faster and more efficient drug discovery and development. By identifying toxic or ineffective drug candidates early on, companies can save billions in R&D costs. This is a significant economic driver, as pharmaceutical and biotechnology companies are under immense pressure to reduce costs while accelerating the time to market for new therapies.

The economic outlook is further strengthened by the growing number of people worldwide with chronic and inherited conditions, which often necessitate a cell-based approach to find effective treatments. The expansion into clinical and diagnostic markets also has a positive economic impact, as it…

Digital Genome Market Economic Outlook

The Digital Genome Market has a very positive economic outlook, driven by the increasing value proposition of genomic data in various sectors. The economic value of these technologies is not only in the sales of instruments and services but also in the long-term cost savings they provide by enabling more precise diagnostics and targeted therapies, thereby reducing the need for costly trial-and-error treatments. Healthcare systems and pharmaceutical companies are increasingly recognizing this value proposition, leading to greater investment and adoption. The economic outlook is further strengthened by the growing number of people worldwide with drug-resistant diseases and inherited conditions, which often necessitate a genomic approach to find effective treatments.

While the high initial cost of advanced sequencing instruments can be a barrier, the market is addressing this challenge through the development of more affordable benchtop sequencers and the proliferation of service providers that make genomic…